Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001019687-16-004858
Filing Date
2016-01-19
Accepted
2016-01-19 06:11:12
Documents
52
Period of Report
2015-07-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 pharmacyte_10qa1-073115.htm 10-Q/A 314863
2 CERTIFICATION pharmacyte_10q-ex3101.htm EX-31.1 7851
3 CERTIFICATION pharmacyte_10q-ex3201.htm EX-32.1 4028
  Complete submission text file 0001019687-16-004858.txt   2585994

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE pmcb-20150731.xml EX-101.INS 506838
5 XBRL SCHEMA FILE pmcb-20150731.xsd EX-101.SCH 25447
6 XBRL CALCULATION FILE pmcb-20150731_cal.xml EX-101.CAL 42854
7 XBRL DEFINITION FILE pmcb-20150731_def.xml EX-101.DEF 103256
8 XBRL LABEL FILE pmcb-20150731_lab.xml EX-101.LAB 199650
9 XBRL PRESENTATION FILE pmcb-20150731_pre.xml EX-101.PRE 182880
Mailing Address 12510 PROSPERITY DRIVE, SUITE 310 SILVER SPRING MD 20904-1643
Business Address 12510 PROSPERITY DRIVE, SUITE 310 SILVER SPRING MD 20904-1643 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

EIN.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 10-Q/A | Act: 34 | File No.: 333-68008 | Film No.: 161346874
SIC: 2833 Medicinal Chemicals & Botanical Products